Observation of Myocardial Injury Markers and No Risk of Reflow in Patients with Acute ST Segment Elevation Myocardial Infarction with Different Electrocardiogram Manifestations
MAO Cun
Yan 'an Hospital of Traditional Chinese Medicine, Yan'an Shaanxi 716000
Abstract:【Objective】 To explore the correlation between electrocardiogram ischemic grading, myocardial injury markers, and no reflow in patients with acute ST segment elevation myocardial infarction. 【Methods】A retrospective analysis was conducted on the clinical data of 80 patients with acute ST segment elevation myocardial infarction admitted to our hospital from January 2019 to January 2022. According to the electrocardiogram ischemic grading, they were divided into grade Ⅱ ischemic group (n=32) and grade Ⅲ ischemic group (n=48). We compared the levels of two groups of myocardial injury biomarkers [high-sensitivity troponin (hs-cTnI), N-terminal B-type brain natriuretic peptide(NT-proBNP), and creatine kinase isoenzyme (CK-MB)], and used receiver operating characteristic (ROC) curves to analyze the value of myocardial injury biomarker indicators in predicting grade Ⅲ ischemia in acute ST segment elevation myocardial infarction. Logistic multiple factor stepwise regression was used to analyze the influencing factors of electrocardiogram ischemia grade Ⅲ in patients with acute ST segment elevation myocardial infarction. 【Results】The proportion of patients in the grade Ⅱ ischemic group without reflow was lower than that in the grade Ⅲ ischemic group, and the levels of hs-cTnI and NT-proBNP were lower than those in the grade Ⅲ ischemic group. The levels of CK-MB were higher than those in the grade Ⅲ ischemic group (P<0.05). ROC curve analysis showed that hs-cTnI, NT-proBNP, and CK-MB levels can all be used for predicting grade Ⅲ ischemia in acute ST segment elevation myocardial infarction, with areas under the curves of 0.861, 0.706, and 0.792 (P<0.05), respectively. Multivariate logistic regression analysis showed that no reflow, hs-cTnI ≥ 1.545 ng/mL, NT-proBNP ≥ 1075.005 ng/mL, and CK-MB<38.253 ng/mL were risk factors for ischemic grade Ⅲ on electrocardiogram in acute ST segment elevation myocardial infarction (P<0.05). 【Conclusion】There are differences in the levels of myocardial injury markers and reflow in patients with acute ST segment elevation myocardial infarction with different electrocardiographic ischemic grades, and myocardial injury markers and no reflow can be used to predict the ischemic grade of acute ST segment elevation myocardial infarction electrocardiograms.
峁存. 急性ST段抬高型心肌梗死不同心电图表现患者心肌损伤标志物及无复流风险观察[J]. 医学临床研究, 2023, 40(12): 1912-1915.
MAO Cun. Observation of Myocardial Injury Markers and No Risk of Reflow in Patients with Acute ST Segment Elevation Myocardial Infarction with Different Electrocardiogram Manifestations. JOURNAL OF CLINICAL RESEARCH, 2023, 40(12): 1912-1915.
[1] SAMSKY M D, MORROW D A, PROUDFOOT A G, et al.Cardiogenic shock after acute myocardial infarction: A review[J].JAMA,2021,326(18):1840-1850.
[2] OZAKI Y, HARA H, ONUMA Y, et al. CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022[J].Cardiovasc Interv Ther,2022,37(1):1-34.
[3] 王永,高江彦,胡建军,等. 冠状动脉内联合应用硝普钠及重组人尿激酶原对急诊PCI术中无复流患者心功能及预后的影响[J].河北医学,2020,26(7):1165-1169.
[4] 陆晨,冯佳佳,何小宇. 血清BNP、cTnI水平与急性心肌梗死患者心肌缺血程度的相关性[J].中华保健医学杂志,2021,23(3):221-223.
[5] 汪品矜,王丽华,徐晓东. 心肌桥心肌缺血病人应用12导联动态心电图对心肌缺血与预后情况的评估价值[J].中国临床研究,2020,33(12):1643-1645.
[6] 沈卫峰,沈迎,张奇,等. 2015年《急性ST段抬高型心肌梗死诊断和治疗指南》解读[J].中国循环杂志,2015,30(2):23-25.
[7] TAN N S, GOODMAN S G, YAN R T, et al. Prognostic significance of low QRS voltage on the admission electrocardiogram in acute coronary syndromes[J].Int J Cardiol,2015,190(6):34-39.
[8] DAMLUJI A A, VAN DIEPEN S, KATZ J N, et al. Mechanical complications of acute myocardial infarction: a scientific statement from the American Heart Association[J].Circulation,2021,144(2):16-35.
[9] GAO G, XU H, ZHANG D, et al. The predictive value of baseline target lesion SYNTAX score for No-reflow during urgent percutaneous coronary intervention in acute myocardial infarction[J].J Interv Cardiol,2021,4(20):995-997.
[10] 黄景慧,张利利,宁萌,等. PCI术后普伐他汀联合氯吡格雷对老年急性心肌梗死患者心肌损伤及NT-proBNP、脂蛋白a、sd-LDL水平的影响[J].中国老年学杂志,2021,41(20):4335-4338.
[11] 饶太萍,李春梅,李俊,等. 心电图QRS波群形态缺血分级与ST段抬高型心肌梗死患者严重心律失常及靶血管的关系研究[J].实用心脑肺血管病杂志,2021,29(2):32-37.
[12] 陈强,李楠,王卓. 重组人脑钠肽对急性心肌梗死患者经皮冠状动脉介入治疗后心肌损伤及心肌重构的影响研究[J].实用心脑肺血管病杂志,2021,29(1):71-75.
[13] 刘亚玲,钟麒. 急性ST段抬高型心肌梗死患者血清心肌损伤标志物水平与心电图缺血分级的相关性[J].现代电生理学杂志,2021,28(2):76-80.
[14] 刘志远,张金盈,刘江波,等. 冠脉内注射重组人尿激酶原溶栓联合PCI对急性心肌梗死患者冠脉血流水平、无复流发生率及预后的影响[J].重庆医科大学学报,2020,45(4):510-516.